Spinal cord injury (SCI) is a debilitating condition which is characterized by an extended secondary injury due to the presence of inflammatory local milieu. Epigallocatechin gallate (EGCG) appears to possess strong neuroprotective properties. Here, we evaluated the beneficial effect of EGCG on recovery from SCI. Male Wistar rats were given either EGCG or saline directly to the injured spinal cord and thereafter a daily IP injection. Behavior recovery was monitored by BBB, plantar, rotarod and flat-beam tests. The levels of inflammatory cytokines were determined on days 1, 3, 7, 10 and 14 after SCI. Additionally, NF-kB pathway activity was evaluated. The results demonstrated that EGCG-treated rats displayed a superior behavioral performance in a flat beam test, higher axonal sprouting and positive remodelation of glial scar. Cytokine analysis revealed a reduction in IL-6, IL2, MIP1a and RANTES levels on days 1 and 3, and an upregulation of IL-4, IL-12p70 and TNFa 1 day following SCI in EGCG-treated rats. Treatment with EGCG was effective in decreasing the nuclear translocation of subunit p65 (RelA) of the NF-kB dimer, and therefore canonical NF-kB pathway attenuation. A significant increase in the gene expression of growth factors (FGF2 and VEGF), was noted in the spinal cord of EGCG-treated rats. Further, EGCG influenced expression of M1 and M2 macrophage markers. Our results have demonstrated a therapeutic value of EGCG in SCI, as observed by better behavioral performance measured by flat beam test, modulation of inflammatory cytokines and induction of higher axonal sprouting.
Introduction
Traumatic spinal cord injury (SCI) is irreversible, with an estimated annual incidence of about 15e40 cases per million (Sekhon and Fehlings, 2001) . Much of the morbidity associated with SCI occurs due to the limited intrinsic ability of the spinal cord to recover following compression or contusion. The pathophysiology of SCI has 2 phases, namely primary injury and secondary injury. Primary injury is the consequence of mechanical insult that includes axons, blood vessels, and cell membrane disruption. Secondary injury that follows after primary injury includes secondary development of edema, ischemia, inflammation, local cytokine production, free radical damage, glial scar formation, apoptosis and necrosis. Recovery from SCI is often hindered by the degree of secondary injury. Perilesional astrocytes exhibit a strong reaction, and changes in morphology resulting in the formation of glial scar composed of a dense extracellular matrix, which occurs over the weeks following SCI (Renault-Mihara et al., 2008) . Moreover, secreted inflammatory cytokines and growth factors enhance the activation of pro-survival pathways such as the NF-kB pathway associated with c-Rel (Ghosh and Hayden, 2008; Ho et al., 2012) . Major obstacles in complete recovery from SCI are, besides others, due to alterations of inflammatory molecules after SCI, therefore understanding therapeutic modalities that stimulate recovery could elucidate the pathophysiology of SCI. Compounds that modulate cytokine levels can be helpful for the recovery from SCI.
Epigallocatechin gallate (EGCG) is a chemical composition of green tea from the family of catechins, which have anti-oxidative/ scavenging, anti-inflammatory and anti-apoptotic effects on neural tissue. It has been shown that EGCG attenuates lipid peroxidation, neural apoptosis, spinal tissue loss, motor dysfunction (Khalatbary et al., 2010) , and inhibits induction of iNOS (Khalatbary and Ahmadvand, 2011) . The neuroprotective effect has been successfully tested on Alzheimer's disease (Walker et al., 2015) , Parkinson's disease (Reznichenko et al., 2010) , amyotrophic lateral sclerosis (Xu et al., 2006) , transient brain ischemia (Park et al., 2010) and in spinal cord injury (Ge et al., 2013) .
The objective of this study was to elucidate the effect of EGCG on the levels of inflammatory cytokines, on activation of the NF-kB pathway, and other cellular and molecular mechanisms underlining the neuroprotective effect of EGCG that cause tissue preservation and better behavioral performance after SCI.
Materials and methods

Animals
Adult male Wistar rats (n ¼ 73) weighing 270e300 g were used in this study. Following spinal cord injury rats were randomly divided into EGCG or saline-treated groups. EGCG (Sigma, 50 mg/ kg, volume 10 ml diluted in saline) was applied directly to the spinal cord surface immediately after spinal cord surgery, and then weekly for up to 28 days after SCI. The wound was reopened 7, 14 and 28 days in very limited range in comparison with the initial SCI surgery. The volume of 10 ml was applied directly on the spinal surface through laminectomy that was performed within SCI surgery. In the meantime, rats were injected with EGCG intraperitoneally (EGCG, Sigma, 50 mg/kg, volume 30 ml diluted in saline) daily. The control group received saline in the same regimen as the EGCG group. For morphometry, behavioral and immunohistochemical analysis, 12 animals from both groups (n ¼ 24) were sacrificed nine weeks after SCI. For cytokine analysis, 5 animals per group and per timepoint (1, 3, 7,10, and 14 days) were utilized (n ¼ 25). To determine the density of p65 nuclear translocation, 12 animals were used in control groups and 12 animals were used in groups treated with EGCG.
All experiments were performed in accordance with the European Communities Council Directive of 22nd of September 2010 (2010/63/EU) regarding the use of animals in research, and were approved by the Ethics Committee of the Institute of Experimental Medicine ASCR, Prague, Czech Republic. The number of animals was statistically optimized for each particular experiment to achieve their reduction.
Spinal cord injury
The balloon compression model was used to create SCI according to Vanicky et al. (2001) . Briefly, after induction of anesthesia (isoflurane 3.5 vol%, Forane, San Juan, Puerto Rico), a 2 French Fogharty catheter (Edwards Lifesciences, Irvine, CA, USA) was inserted through a small opening in the T10 vertebra cranially, so that the center of the balloon rested at the T8 spinal level. The balloon was inflated with 15 ml volume of saline for 5 min. After removing the balloon, the wound was sutured in anatomical layers. To avoid hypo-hyperthermia (Urdzikova and Vanicky, 2006) , the rat's body temperature was kept at 37 C with a heating pad. The animals developed complete paraplegia for 2e3 days following SCI, with gradual recovery within 9 weeks. Manual bladder expression due to urine retention, and assisted feeding was provided during the recovery phase. The animal received gentamicin sulfate (5 mg/ kg, Sandoz, Czech Republic) to prevent post-surgery infection. Animals were kept at a 12 h light/dark cycle with access to water and standard rat chow ad libitum, and examined daily for the occurrence of SCI side complications.
Functional analysis
The flat beam test was used to analyze the complex motor performance of the rats after SCI. The apparatus consists of a 3.4-cm-wide and 140-cm-long wooden rectangular beam with a goal box placed at the end. Only the central 1 meter long part of the beam was selected for the motor performance evaluation. A videotracking system (TSE-Systems Inc., Bad Homburg, Germany) recorded and evaluated the latency and trajectory of the rat to traverse the beam for a maximum of 60 s. Animals were pre-trained before spinal cord surgery, and then again before each testing. Rats were scored using the modified Goldstein score (Goldstein et al., 1997 ) on a scale from 0 to 7, starting with no ability to balance and progressing to crossing the whole length of the beam properly using both hindlimbs.
The Basso Beattie and Bresnahan (BBB) test was used to determine hindlimb locomotor performance (Basso et al., 1995) . The rats were placed into the circular arena and scored using 0e21 point scale. The BBB score reflects their joint movement, paw placement, weight support, forelimb-hindlimb coordination and trunk stability, 0 reflects no movement and 21 reflects normal performance.
Hindpaw withdrawal latency to a thermal stimulus was evaluated utilizing the specialized Plantar test apparatus (Ugo Basile, Comerio, Italy). Rats were placed into the closed chamber and received thermal stimulus to the hindpaws through a glass plate. The withdrawal latency was measured 5 times for each hindpaw. The average of five values was used for statistical evaluation.
BBB and plantar tests were performed prior to spinal cord surgery and then weekly after SCI.
A Rotarod unit (Ugo Basile, Comerio, Italy) was used to test the motor function and forelimb-hindlimb coordination of the rats. Rats were pre-trained before SCI. For evaluation fix speed (5 rpm) was used, and the latency to fall from the rotating rod was recorded.
The rotarod test and flat beam test require more complex motor abilities of the rats, so the testing procedures started the 3rd week after SCI and then 5, 7 and 9 weeks after surgery.
Histological and immunohistochemical analysis
For histological and immunohistochemical analyzes, 12 rats from each group surviving 9 weeks, and all rats destined for NF-kB activity analysis were transcardially perfused with 4% paraformaldehyde at the end of a designated end point. Briefly, animals were deeply anesthetized with an overdose of penthobarbital, administrated intraperitoneally; their chests were opened and transcardiac perfusion with phosphate buffer was followed by perfusion with 4% paraformaldehyde in phosphate buffer. Their spines were dissected and left in 4% paraformaldehyde for postfixation overnight. The next day, 2 cm long spinal cords containing spinal cord lesions were removed from the spinal column for further processing.
For morphometric and immunohistochemical analysis, spinal cords were mounted in paraffin and serially sectioned (5 mm crosssections, 1 mm interval). Luxol Fast Blue and Cresyl Violet staining were selected to distinguish white and gray matter. To measure the area of spared white and gray matter, Axioskop 2 plus microscope (Zeiss, Oberkochen, Germany) and ImageJ software (Wayne Rasband, NIH, Bethesda, MD, USA) were utilized. We also measured the volume of the cavities that are developed in the area of the spinal cord lesion 9 weeks after SCI. First, we measured the area of the cavity on serially sectioned spinal cords and then we calculated the volume of the cavity for each spinal cord. To evaluate axonal sprouting and astrogliosis, the primary antibodies against GAP43 (Millipore, Billerica, MA, USA) and GFAP conjugated with CY3 (Sigma, St. Louis, MO, USA) were used. As a secondary antibody, goat anti-mouse IgG conjugated with AlexaFluor 488 (Abcam, Bristol, UK) was utilized. For immunohistochemical analysis ZEISS AXIO Observer D1 microscope (Carl Zeiss, Weimar, Germany) was used. Graphics were processed with Excel (Office 2010, Microsoft) and CorelX6 (Corel Corporation) software.
Anti NF-kB (p65) staining followed by hematoxylin staining was perfomed on paraffin embedded 5 mm cross-sections, using primary rabbit IgG antibody against p65 (Santa Cruz, Dallas, USA) and secondary goat IgG antibody conjugated with horseradish peroxidase H (Vector Laboratories, Burlingame, USA). To visualize p65, DAB and H 2 O 2 were added to allow the formation of brown precipitate. Microscope LEICACTR6500 with software FAXS 4.2.6245.1020 (TissueGnostics, Vienna, Austria) were used to take images of spinal cross sections. The density of translocated p65 into cell nuclei was evaluated using analysis software HistoQuest 4.0.4.0154 (TissueGnostics, Vienna, Austria).
qPCR
The expression of rat target genes Sort1 (Nt-3), Fgf2, Olig2, Gap43, Gfap, Vegfa, Nfkb1, Cntf, Cd86, Irf5 (M1 macrophage phenotype), and Cd163 and Mrc1 (M2 macrophage phenotype), 10 and 28 days after SCI, was performed using a quantitative real-time reverse transcription polymerase chain reaction (qPCR). RNA was isolated from paraformaldehyde-fixed spinal cord tissue sections, with 4 spinal cords for each time point, using the High Pure RNA Paraffin Kit (Roche, Penzberg, Germany). RNA amounts were quantified with a spectrophotometer (NanoPhotometerTM P-Class, Munchen, Germany), and isolated RNA was reverse transcribed into cDNA using Transcriptor Universal cDNA Master (Roche, Penzberg, Germany) and a thermal cycler (T100™ Thermal Cycler, Bio-Rad, Hercules, CA, USA). The qPCR reactions were performed using a cDNA solution, FastStart Universal Probe Master (Roche, Penzberg, Germany) and TaqMan ® Gene Expression Assays (Life Technologies, Carlsbad, CA, USA). The qPCR was carried out in a final volume of 10 mL containing 25 ng of extracted RNA. A real-time PCR cycler (StepOnePlus™, Life Technologies, Carlsbad, CA, USA) was used for amplification. We kept the following cycling conditions: 2 min at 50 C, 10 min at 95 C, followed by 40 cycles of 15 s at 95 C and 1 min at 60 C. Relative quantification of gene expression was determined using the DDCt method [31] . The data were analyzed with StepOnePlus ® software (Life Technologies, Carlsbad, CA, USA).
For the normalization of gene expression levels we used the Gapdh gene as a reference. A log2 scale was used to display the symmetric magnitude for up and down regulated genes. From the obtained values of the control animals (SCI treated with vehicle), the arithmetical mean was calculated and one control was set as zero. The statistical analysis was performed from DCt values of controls as well as EGCG-treated animals.
Cytokine evaluation
Levels of inflammatory cytokines in the spinal cord after EGCG and saline treatment were determined 1, 3, 7, 10 and 14 days after SCI. Fresh spinal cords were removed and kept on ice, and a 2 mm long segment from the center of the lesion was dissected and incubated in cell culture media (DMEM, Sigma, St. Louis, MO, USA), supplemented with 10% FBS and 0.2% primocin for 24 h, and secretory cytokine levels were detected in the collected media. A customized Milliplex inflammatory cytokine kit (Millipore, Billerica, MA, USA) and Luminex instrumentation software were used to analyze inflammatory cytokines. Rat cytokine Luminex custom eight-plex kits (for IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IFNg, TNFa, MIP-1a) were used for customized bead assays. The assays were performed in 96-well filter bottom plates according to the manufacturer's protocol. Antibody conjugated beads were used at a concentration of 5000 beads per marker and were incubated overnight with the samples. A biotinylated detection antibody with streptavidin-RPE (streptavidin-R-Phycoerythrin) (Life Technologies, Carlsbad, CA, USA) was used to measure the levels of cytokines on a Luminex xMAP 200 system (Luminex, Madison, WI, USA). Data were processed using Magpix instrumentation software. Mean fluorescence intensity (MFI) was used to calculate the concentration of each cytokine; a four-or five-parameter logistic fit curve was generated for each cytokine from seven standards. The lowest standard, at least three-times above the background, was used to determine the lower limit of quantification (LLOQ). The LLOQ was calculated by subtracting the MFI of the background (diluent) from the MFI of the lowest standard concentration and back-calculating the concentration from the standard curve (Machova Urdzikova et al., 2016) .
Statistic
For the purpose of comparison of EGCG and saline-treated animals after SCI, several statistical tests were used. For behavioural part of the study, glial scar, astrocyte morphology and GM/WM analysis the two way repeated measurement ANOVA was applied. For immunohistochemical Gap43 and cavity size analysis student nonpaired nonparametric T-test was used. For NFkb analysis three way ANOVA was applied. For the relative gene expression of regenerative processes related genes and for cytokine analysis a two way ANNOVA was applied. As a posthoc pair to pair Student Neuman Keuls test was used. All data in graps are expressed as arithmetical means with standard error of mean included. Significance in the text or in the graf is marked according scheme; *p<0.05, **p<0.01, ***p<0.001.
Results
Functional analysis
Flat beam test and flat beam score
Flat beam test was used to measure the recovery of motor function and coordination of the hindlimbs (Fig. 1A,B) . Performance on the balance beam is a useful measure of fine coordination and balance. The flat beam test can detect precisely the motor deficits influenced by pharmacological manipulations in rats. Immediately after SCI, the performance of rats treated with EGCG started to slowly improve, when compared to saline-treated animals, and in the 6th week we observed a significant improvement in their ability to cross the beam with respect to time (ANOVA F¼4.327 p¼0.051 SNK test 6 week q¼3.189 p<0.05; 7 week q ¼ 3108 p<0.05; 8 week q¼3.322 p<0.05; 9 week q¼3.459 p<0.05) and score (ANOVA F¼4.192 p¼0.055, SNK test 6 week q¼3.267 p<0.05; 7 week q¼3.509 p<0.05; 8 week q¼3.228 p<0.05; 9 week q ¼ 3.295 p<0.05).
BBB test
Hindlimb locomotion was examined weekly using the BBB motor performance test (Fig. 1C) . Immediately after balloon-induced spinal cord compression lesion, rats were scored with 0, which represented no movement of the hindlimbs. In the first postsurgical weeks rats regained their abilities to move with all three joints of the hindlimbs, but no significant difference appeared after the EGCG treatment when compared to the saline treatment. After the 5th week post injury, a gradual recovery continued, and rats from the saline and the EGCG-treated group reached a similar level of uncoordinated stepping. There was no significant difference in BBB scores between EGCG and saline-treated groups in terms of overall functional motor recovery during the whole survival time (p>0.05).
Plantar test
The withdrawal latency of the hindlimbs to the thermal stimulus was evaluated once per week (Fig. 1D) . The latency of both groups slightly decreased during the second and third weeks after spinal cord lesion induction in EGCG and saline-treated rats. After the 4th week, withdrawal times were stabilized and no significant The rotarod test showed that the ability to balance on the rotating pole remained at the same level during the entire testing period in saline and EGCG groups. *p < 0.05 indicates statistical significance, BI-before injury.
differences were observed between the two groups. Both groups maintained the same level of sensitivity to thermal stimulation and no statistical differences were observed between the groups during the entire experimental period. Slight hyperalgesia, resulting from SCI was not affected by EGCG treatment.
Rotarod test
Rotarod scores express the ability of rats to balance on a rotating pole. This test requires the most advanced motor skills out of all the tests applied in the experiment. Before spinal cord injury, animals were able to balance on the rotating pole for more than 60 s. After the induction of spinal cord injury, rats were able to balance on the beam for only a few seconds, and this performance did not improve until the end of the designated survival time of 9 weeks (Fig. 1E ). In conclusion, no improvement of rotarod score and no significant differences were observed between EGCG and saline treatment in the ability to balance on the rotating pole.
Histology and immunohistochemistry
White and gray matter
The morphometric measurement was performed to measure the preservation of the spinal cord tissue after EGCG or saline treatment. The white matter of the spinal cords treated with EGCG was mostly preserved in the cranial part of the spinal lesion when compared to controls, but did not reach statistical significance (Fig. 2A) . The EGCG treatment ensured that the gray matter was more spared in both caudal and cranial parts of the spinal lesion compared to controls (Fig. 2B) , and reached significance at 5 mm caudally from the lesion center (SNK test q¼3.081 p<0.05). The volume of the cavities was similar in both groups, no statistical significance was observed (Fig. 2E ).
Glial scar
Glial scar formation was compared between EGCG and salinetreated groups. The area of the glial scar was larger in salinetreated rats compared to EGCG-treated rats, but did not reach statistical significance. The number of protoplasmic astrocytes was higher in saline -treated rats and reached statistical significance at 3 mm cranially from the lesion center (ANOVA F¼4.81 p¼0.064; 3 q¼2.907 p<0.05) (Fig. 2D) .
Axonal sprouting
The level of axonal sprouting expressed as the number of GAP 43 positive fibers in saline and EGCG treated rats showed that axonal regeneration was significantly higher in EGCG-treated rats compared to saline-treated rats (t-test t ¼ -3.12 p<0.05) (Fig. 3B) . The illustrative image of GAP43 positive fibbers in spinal cord from EGCG-treated rat is depicted in Fig. 3A. 
Activity of NF-kB pathway
Activity of the NF-kB pathway was established by calculating the density of p65 þ nuclei per1 mm 2 of tissue 3, 7 and 28 days after spinal cord injury (Fig. 4) . Treatment with EGCG proved to be significantly effective in decreasing NF-kB activity in all the studied time points when compared with controls treated with saline (Three way ANOVA F ¼ 30.469 p<0.001). Density of p65 þ nuclei 3 days after injury was significantly reduced in the lesion center (SNK test q ¼ 3.73 p<0.05), whereas 7 days after injury such a reduction was observed cranially from the center of the lesion site (SNK test q ¼ 3.476 p<0.05). Moreover, the activity of p65 associated NF-kB pathway was markedly reduced in all evaluated regions of spinal cord injury, cranial, central and caudal 28 days after SCI (SNK test Cranial q¼3.228 p<0.05; Center q¼4.916 p<0.01; Caudal q¼3.19 p<0.05). Fig. 5 shows the activated NF-kB with p65 located in nucleus as well as incativated and negative cells.
qPCR
We investigated expressions of genes related to growth factor production (Vegfa, Sort1, Fgf2, Cntf), axonal sprouting (Gap43) glial cells response (Gfap, Olig2) and inflammatory processes (Cd86, Cd163, Irf5, Mrc1, and Nfkb1), 10 and 28 days after SCI (Fig. 6) 
Cytokines
We investigated the levels of secreted inflammatory cytokines 1, 3, 7, 10 and 14 days after spinal cord injury in both the saline and EGCG-treated groups (Fig. 7) . The greatest effect of EGCG treatment was observed on the first day after spinal cord injury. The levels of MIP-1a (SNK test 1 day q¼5.109 p¼0.001), IL-6 (two way ANOVA F¼5.819 p<0.05; SNK test 1 day q ¼ 6.453 p p<0.001) and RANTES (two way ANOVA F¼10.812 p<0.01; SNK test 1 day q¼3.817 p<0.05; 3 day q¼3.361 p<0.05) were significantly reduced after EGCG treatment compared to controls and remained on a similar level for the whole week. The levels of IL-4 (Two way ANOVA F¼3.239 p ¼ 0.084; SNK test 1day q¼3.338 p<0.05) showed strong tendency to increase in the EGCG-treated group compared to the saline treatment. With time, the overall inflammatory response decreased. The level of IL-2 was significantly reduced 3 days after SCI in the EGCG-treated group. The levels of IL-12, p70 (SNK test 1day q¼4.208 p<0.01; 7days q¼4.375 p<0.01) and TNF-a (SNK test 1day q¼3.654 p<0.05) after significant upregulation on the first day after SCI gradually decreased during the first week of treatment, while in controls these cytokines showed the opposite trend. The level of IL-1b (SNK test q¼4.334 p<0.01) was significantly higher in the EGCG-treated group 14 days after SCI compared to controls.
Discussion
The main purpose of this study was to assess if EGCG may regulate inflammatory process in spinal tissue after SCI to improve recovery in rats. Our results indicate that EGCG injected locally and systemically improves the behavioral outcome after SCI in some of the tests (such as flat beam test), facilitates axonal sprouting and grey matter sparing, and upregulates the expression of VEGF and FGF2. EGCG also alteres the expression of different macrophage markers, and modulates the inflammatory response by suppressing NF-kB activity, decreasing levels of inflammatory cytokines IL-6, IL2, MIP1a and RANTES, and changing the time profile of the release of IL-4, IL-12p70 and TNFa within the first week after SCI.
The EGCG neuroprotective effect is a result of free radical scavenging and metal chelating properties (Yu et al., 2010) . It was shown that EGCG also modulated production of neurotrophic factors, decreased inflammation and neuronal cell apoptosis and improved recovery after SCI (Tian et al., 2013) .
We observed an improvement in motor performance in more complex performance tasks. The less specific open field locomotor BBB test did not show any significant improvement, which is in agreement with the findings of Alvarez-Perez et al. (Alvarez-Perez et al., 2016) , where the application of EGCG after mice spinal cord contusion injury also did not lead to locomotor recovery measured by open field test. Statistical significance was observed using the flat beam test which combines motor abilities together with motivation and social behavioral skills. As was previously reported, EGCG consequently moderates an acute stress response (Adachi et al., 2006) and improves spatial cognitive learning ability, due to its anti-oxidative activity (Haque et al., 2006) . EGCG treatment also improve the learning and memory in stress related impairment (Soung et al., 2015 #76) . Chronic EGCG treatment also ameliorates learning and memory deficits in diabetic rats (Sanadgol et al., 2016 #142 ). An enhancement in the flat beam test could then be caused by an improvement of these abilities more than only motor skills.
The sensory function and thermal hyperalgesia of the rats was measured by the plantar test, which measures withdrawal latency of the hindlimbs to the thermal stimulus. In our study, EGCG did not Fig. 2. Histopathological analysis. (A,B) Morphometric measurement revealed a trend in the sparing of white matter in EGCG when compared to the control group. Gray matter was significantly more spared in the EGCG group 5 mm caudally from the lesion center, however, the trend in gray matter sparing was also observed in the cranial part of the spinal cord lesion. (C, D) Glial scar formation was similar in both groups, but the number of protoplasmic astrocytes was significantly lower after EGCG-treated rats. (E) The size of the cavities in the spinal cord tissue was similar in both groups. *p < 0.05 indicates statistical significance. Fig. 4 . NF-kB activity. Treatment with EGCG significantly reduced p65 associated NF-kB pathway activation 3 days after SCI in the lesion center. Overall, the effect of EGCG was significant when compared to saline controls. (B) A significant reduction in p65 þ nuclei density was observed 7 days after SCI, with a local significant difference in the cranial part of the spinal cord injury. (C) 28 days after SCI, density of p65 þ nuclei was further decreased and EGCG treatment reached a high significance. A significant decrease in p65 associated NF-kB activity was measured in the cranial part and central part, as well as the caudal part of injury. (A, B, C) Additionally, three-way ANOVA revealed an overall significance of EGCG in decreasing p65 þ nuclei density. *p < 0.05, **p < 0.01 indicate statistical significance.
influence thermal nociception, whereas in studies using chronic constriction nerve injury or spinal nerve ligation, EGCG reduced the chronic thermal hyperalgesia (Xifro et al., 2015) , down regulating RhoA, FASN and TNF-a protein expression, reduced neuropathic pain due to the suppression of ROS in the spinal cord and has an anti-allodynic effect mediated by a blockade of nNOS protein expression, and inhibition of the pro-nociceptive effects of NO (Choi et al., 2012) . These studies were using different models of nerve injury (chronic constriction nerve injury, spinal nerve ligation). The balloon compression spinal cord injury model used in this study produces severe spinal cord injury with progressive recovery of the motor function, which does not lead to chronic pain or severe hyperalgesia. Therefore the effect of EGCG on thermal hyperalgesia was not so distinct.
Previous studies have shown that EGCG has a neuroprotective effect. This effect could be explained by its anti-apoptotic activity (Tian et al., 2013) , anti-inflammatory effect (Khalatbary and Ahmadvand, 2011) , neurotrophic factor release (Renno et al., 2016; Tian et al., 2013) , or direct radical scavenging effect (Choi et al., 2012) . Khalatbary et al. performed similar study with EGCG on contusin spinal cord injury (Khalatbary and Ahmadvand, 2011) . This group injected one dose (50 mg/kg i.p.) immediately or one hour after injury. They reported neuroprotective effect, based on HE staining performed on 8 sections from the lesion epicenter 6 weeks after SCI. We analyzed the whole 15 mm long segment 9 weeks after SCI using cresyl violet and luxol blue staining to distinguish gray and white matter. In our study, treatment with EGCG ensured to some extend the sparing of gray matter and increased axonal sprouting compared to the saline treatment. The protective effect was more pronounced in grey matter than in white matter. This contradiction can result from different type of lesion, different time point of evaluation or different method of assessment. An increase of axonal sprouting, assessed by GAP43 positivity after the application of EGCG was described not only in SCI (Renno et al., 2015) , but also in a model of sciatic nerve crush injury, and our results are fully in compliance with these studies.
One of the adverse effects of SCI is glial scar formation. The influence of EGCG on glial scar modulation is controversial. While in Fig. 7 . Levels of proinflammatory cytokines 1, 3, 7, 10 and 14 days after SCI in EGCG and saline-treated groups. The levels ofMIP-1a, IL-6 and RANTES were downregulated after EGCG treatment compared to saline treatment 1 day after SCI. The levels of IL-1b (14 days), IL-4 and TNF-a (1 day) were significantly upregulated in EGCG-treated group. The first day after SCI, IL-12 p70 was upregulated after EGCG treatment, but 7 days after SCI was significantly reduced compared to controls. sciatic nerve crush injury models and spinal cord contusion, the injury decrease in GFAP expression was described (Alvarez-Perez et al., 2016; Renno et al., 2015) , in mild thoracic SCI an increase in GFAP immunohistochemistry was reported (Renno et al., 2014) . Our study showed a trend in the decrease of GFAP immunoreactivity in the center of the lesion and a lesser number of protoplasmic astrocytes after EGCG treatment.
Application of EGCG influences the expression of growth factors. Immunohistochemical investigation and Western blot analysis by Tian et al. revealed that EGCG applied intrathecally enhanced the expression of two growth factors -brain derived neurotrophic factor and glial cell derived neurotrophic factor (Tian et al., 2013) . We found that EGCG treatment significantly elevated the gene expression of Fgf2 and Vegf. Goldshmit et al. showed that exogenous fibroblast growth factor applied after SCI had a positive effect on glial scar modulation, decreased the expression of TNF-a at the lesion site, and decreased monocyte/macrophage infiltration (Goldshmit et al., 2014) . The study of Young showed that application of VEGF after SCI improved the motor performance of the rats and had an anti-inflammatory effect, together with supporting autophagy function . Elevated gene expression of those two factors after EGCG treatment in our study could lead to higher gray matter sparing, axonal sprouting and glial scar modulation.
Inflammation is often associated with the activation of the NFkB pathway, which mediates several inflammatory cytokines, chemokines, enzymes, adhesion molecules and kinases (Aggarwal and Harikumar, 2009; Begum et al., 2008; Chainani-Wu, 2003) . EGCG decreased the activity of the NF-kB pathway, which was accompanied by a decrease of RANTES, IL2, IL6, MIP1a and IL12 during the first week after SCI. This effect was similar to the effect of another natural anti-inflammatory compound curcumin, where we also observed a decrease of IL2, MIP1a, IL12 and additionally TNF-a during the first seven days after SCI (Machova Urdzikova et al., 2016) . It has been shown that in rodents one of the EGCG targets is the Toll-like receptor 4 (TLR4), which is inhibited, and that in turn causes a downstream inhibition of the NF-kB pathway both in the peripheral and central nervous system (Kuang et al., 2012; Seong et al., 2016) ; this is also one of the mechanisms of action of the compound curcumin (Youn et al., 2006) . However, the dynamics of EGCG treatment is different than that of curcumin, since 1 day after SCI the majority of cytokines were increased after EGCG treatment, while they decreased after curcumin application. It can be explained either by slower effect than curcumin, or at high doses, EGCG might have pro-inflammatory effect at short term, before developing anti-inflammatory effects. This can explain the opposite effect of curcumin on behavioral outcome, where the greatest improvement in locomotor recovery was observed during the first week after SCI. TNF-a is a major mediator of inflammation in most diseases. Application of EGCG resulted in oscillation of TNF-a levels.
After an increase 1 day after SCI, we observed a decrease of TNF-a up to 14 days post injury with an insignificant increase 10 days after SCI. Similar results were obtained in a study by Alvarez-Perez, where TNF-a proteins were reduced 7 and 14 days after EGCG application in a spinal contusion model (Alvarez-Perez et al., 2016) . Xifro et al. reported a decrease in TNF-a 14 days, but not 56 days post injury (Xifro et al., 2015) . Another positive effect of EGCG on recovery after trauma to the central nervous system is attenuation of apoptosis, through the upregulation of anti-apoptotic Bcl-2 and downregulation of Bax (Khalatbary et al., 2010; Tian et al., 2013) , and prevention of Nogo-A activity, which causes the collapsing of growth cones of regenerating axons (Gundimeda et al., 2015) . Macrophages are recognized as classical M1 macrophages (iNOS positive) and activated M2 macrophages (Arg-1positive). While accumulation of M1 macrophages enhance inflammation in the neural tissue, M2 macrophages are believed to block inflammatory responses and promote tissue repair. However, these M1/M2 definitions are based mainly on in vitro studies whilst, recently is evident that activated microglia for example during traumatic brain injury can coexpress the canonical gene products of both polarized states (Morganti et al., 2016 #340) . EGCG treatment can therefore influence the expression of different macrophage markers, altering the macrophage phenotype and modulating the inflammatory reaction after traumatic SCI.
In conclusion, our results demonstrated a possible therapeutic value of EGCG in SCI, as observed by better behavioral performance in flat beam test, which is influenced by its ability to alter macrophage phenotype, modulate inflammatory cytokines at an early stage of SCI and induce higher axonal sprouting. However, further studies with different therapeutic doses and routes of application are needed. EGCG' therapeutic potential might be also reinforced by subsequent therapy to facilitate long-term tissue reconstruction.
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